Alexion Pharmaceuticals (United States)

Alexion Pharmaceuticals (United States)

Alexion Pharmaceuticals, Inc., a subsidiary of AstraZeneca, is a pharmaceutical company headquartered in Boston, Massachusetts that specializes in orphan drugs to treat rare diseases. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Alexion Pharmaceuticals (United States), United States, covering academic research published from 2000 to 2024. Read More.


Open Access Percentage

52%


Total
Publications

980


Total Open
Publications

509


Total
Citations

37K


Open Access
Percentage

52%


Total
Publications

980


Total Open
Publications

509


Total
Citations

37K

Wikipedia

Website

download

Breakdown

16% 31% 4% 49%

Publisher Open

16%

Both

31%

Other Platform Open

4%

Closed

49%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0102030405060708090100Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

46%OA Journal

OA Journal 46%

210

Hybrid 28%

129

No Guarantees 26%

119

Other Platform Open

Domain 82%

287

Institution 28%

98

Other Internet 11%

38

Preprint 2%

8

Public 1%

5

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
290
DOI
Other Internet
36
DANS - Data Archiving and Networked Services
Institution
29
Europe PMC
Domain
17
Elsevier - Scopus
Institution
16
Ghent University - Ghent University Academic Bibliography
Institution
11
Universidad Autónoma de Madrid - Biblos-e Archivo
Institution
9
Sapienza University of Rome - IRIS Research product catalog
Institution
9
Le Centre pour la Communication Scientifique Directe - HAL - Diderot
Institution
8
Research Square
Preprint
7
1 / 6

Data updated 18 August 2025

Share

Share

Share